Richter expects Q1 profit to fall on weak ruble
Pharmaceutical producer Richter expects its first-quarter operating profit margin to plumb record lows due to the fall in the value of the ruble, as Russia is its biggest market, CEO Erik Bogsch told Reuters in an interview published Wednesday.
Bogsch went on to state that the Richter EBIT margin could end up “below 10%,” a record-low mark for the company. “Just how much below [10%] is not yet clear, but it will be well below that level.”
Early in February, after Richter published its earnings report for the fourth quarter of 2013, Bogsch announced an expected decrease in revenue for Q1 2014 despite a then-expected increase in sales to Russia by as much as 5% year-on-year, calculated in rubles.
The ruble has decreased 20% in value against the euro in the past nine months.
Russian sales generated 28.4% of Richter’s turnover in 2013.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.